Are nuts good for your heart and your weight?
For most people, a daily handful of nuts is a well-supported choice for a healthier heart. Those who want to lose weight or prevent diabetes cannot count on nuts achieving that on their own.
A handful of nuts per day (about 28 grams) is associated with a clearly lower risk of cardiovascular disease. Large umbrella analyses show that this risk drops by around 21% compared with eating no nuts at all. In those same analyses, the chance of premature death was approximately 22% lower among regular nut eaters1,2. That pattern recurs across multiple large population studies, which strengthens the association.
The strongest direct evidence comes from the PREDIMED study with 7,447 participants over an average of 4.8 years. People who followed a Mediterranean diet that included nuts had a 30% lower chance of a heart attack, stroke, or death from cardiovascular disease than the control group3,4. The nut group also showed a much greater reduction in metabolic syndrome: a 13.7% reduction, compared with 6.7% and 2.0% in the other groups. Nuts played a role here as part of a Mediterranean diet, not as a standalone intervention.
How nuts achieve this is reasonably well understood. They lower LDL cholesterol, reduce inflammation and oxidative stress, and improve blood vessel function2,1. A protective effect against stroke does exist, but it is less well supported than the effect on heart attacks2.
For body weight, the picture is less clear. Nuts are calorie-dense, but the available studies give no reason to think that one portion per day causes weight gain. A proven slimming effect cannot be substantiated on the basis of this research either1,5. Whether nuts lower the risk of type 2 diabetes is likewise uncertain. In PREDIMED, the effect of the nut group on diabetes was not statistically reliable, and broader review studies give mixed signals3,1.
Finally, approximately 1 to 2 percent of adults have a nut allergy or another adverse reaction. This advice obviously does not apply to them1.
Based on two large umbrella meta-analyses (PMID 36041171, 29800597) and the randomised PREDIMED trial (PMID 24829485, 25940230, 25447615). PREDIMED was later partly re-analysed due to a randomisation error in one sub-centre, but the revised analysis confirmed the main findings.